February 01, 2018

in Benefits & Health, Government Updates

Prices expected to be reduced for some of the most commonly prescribed drugs in Canada

The pan-Canadian Pharmaceutical Alliance (pCPA), with the Canadian Generic Pharmaceutical Association (CGPA) announced earlier this week that as of April 1, 2018, the prices of nearly 70 of the most commonly prescribed drugs in Canada will be reduced by 25% – 40%. These drugs include those used to treat high blood pressure, high cholesterol, and depression, and are collectively used by millions of Canadians.

This initiative will provide savings to patients and improve pricing in Canada relative to other countries, as well as increase the sustainability of drug plans and improve pricing consistency across the country.

The list of generic drugs subject to further price discounts effective April 1, 2018 will be published on the Saskatchewan formulary website.